Interpretive Practice Atlas
The interpretive practice atlas that follows has not been designed to serve as a typical atlas, in the sense of presenting a set of prototypical examples of a wide variety of clinical entities. Rather, it has been designed to provide actual clinical cases involving a series of brain positron emission tomography (PET) imaging sets that pose interpretive challenges that readers can realistically and repeatedly expect to face in most current clinical environments—where often the patient’s symptoms are mild or even questionable at the time of initial evaluation and the associated metabolic findings may be subtle.
KeywordsPositron Emission Tomography Executive Functioning MMSE Score Frontotemporal Dementia Posterior Cingulate Cortex
- 3.3. Silverman DHS, Truong CT, Kim SK,. Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET. Molec Genet Metab 2003;80:350–355.PubMedCrossRefGoogle Scholar
- 14.14. Fago JP. Dementia: causes, evaluation, and management. Hosp Pract (Minneap) 2001;36:59–66, 69.Google Scholar
- 15.15. Whitehouse PJ, Friedland RP, Strauss ME. Neuropsychiatric aspects of degenerative dementias associated with motor dysfunction. The American Psychiatric Press Textbook of Neuropsychiatry, 2nd ed. Washington, DC: American Psychiatric Press, 1992, pp 585–604.Google Scholar
- 23.23. Corey-Bloom J, Anand R, Veach J. A randomized trial evaluating the efficacy and safety of ENA 713 rivastigmine tartrate, a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer’s disease: the ENA 713 B352 Study Group. Int J Geriatr Psychopharmacol 1998;1:55–65.Google Scholar